Release Date: 21/09/22 17:22 Summary: Date of Annual General Meeting Price Sensitive: No Download Document 75.61KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%